Finnish noninvasive brain stimulation company Nexstim PLC is eyeing the US as the first launch market for its Navigated Brain Therapy system for post-acute stroke treatment once it completes an ongoing pivotal trial.
Nexstim CEO Janne Huhtala says in an interview that the US stroke rehabilitation centers offer a unique marketing opportunity because “right now, nobody else is selling anything to these guys, and that's what
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?